dostarlimab
gsk
['rectal']
really interesting presentation by at #asco22! #pd-1 blockade as treatment in mismatch repair deficient locally advanced rectal cancer. 100% clinicla complete response in the first 14 patients! no grade 3-4 ae's! #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB